ADAMIS PHARMACEUTICALS CORP's ticker is ADMP and the CUSIP is 00547W208. A total of 51 filers reported holding ADAMIS PHARMACEUTICALS CORP in Q4 2022. The put-call ratio across all filers is 0.02 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $28,353 | -31.5% | 244,634 | 0.0% | 0.00% | – |
| Q4 2022 | $41,417 | -15.5% | 244,634 | 0.0% | 0.00% | – |
| Q3 2022 | $49,000 | -60.2% | 244,634 | 0.0% | 0.00% | – |
| Q2 2022 | $123,000 | -16.9% | 244,634 | -5.5% | 0.00% | – |
| Q1 2022 | $148,000 | -5.7% | 258,851 | 0.0% | 0.00% | – |
| Q4 2021 | $157,000 | -37.5% | 258,851 | 0.0% | 0.00% | – |
| Q3 2021 | $251,000 | -11.9% | 258,851 | 0.0% | 0.00% | – |
| Q2 2021 | $285,000 | +17.3% | 258,851 | 0.0% | 0.00% | – |
| Q1 2021 | $243,000 | +192.8% | 258,851 | +50.5% | 0.00% | – |
| Q4 2020 | $83,000 | -34.6% | 171,988 | +5.7% | 0.00% | – |
| Q3 2020 | $127,000 | +38.0% | 162,686 | -5.5% | 0.00% | – |
| Q2 2020 | $92,000 | +130.0% | 172,210 | +55.3% | 0.00% | – |
| Q1 2020 | $40,000 | -48.7% | 110,872 | 0.0% | 0.00% | – |
| Q4 2019 | $78,000 | 0.0% | 110,872 | 0.0% | 0.00% | – |
| Q3 2019 | $78,000 | -32.2% | 110,872 | +25.4% | 0.00% | – |
| Q2 2019 | $115,000 | -38.5% | 88,432 | 0.0% | 0.00% | – |
| Q1 2019 | $187,000 | -49.9% | 88,432 | -46.8% | 0.00% | – |
| Q4 2018 | $373,000 | -37.2% | 166,170 | -2.0% | 0.00% | – |
| Q3 2018 | $594,000 | +36.6% | 169,628 | +24.7% | 0.00% | – |
| Q2 2018 | $435,000 | -11.0% | 136,020 | -2.5% | 0.00% | – |
| Q1 2018 | $489,000 | +19.9% | 139,536 | +50.7% | 0.00% | – |
| Q4 2017 | $408,000 | +40.2% | 92,612 | +66.6% | 0.00% | – |
| Q3 2017 | $291,000 | +9.4% | 55,596 | +8.8% | 0.00% | – |
| Q2 2017 | $266,000 | +29.1% | 51,108 | +5.5% | 0.00% | – |
| Q1 2017 | $206,000 | +92.5% | 48,422 | +42.0% | 0.00% | – |
| Q4 2016 | $107,000 | +4.9% | 34,090 | +14.2% | 0.00% | – |
| Q3 2016 | $102,000 | +24.4% | 29,859 | +1.6% | 0.00% | – |
| Q2 2016 | $82,000 | -67.1% | 29,397 | -27.7% | 0.00% | – |
| Q1 2016 | $249,000 | -16.7% | 40,641 | -26.7% | 0.00% | – |
| Q4 2015 | $299,000 | +50.3% | 55,443 | +8.0% | 0.00% | – |
| Q3 2015 | $199,000 | +201.5% | 51,343 | +226.1% | 0.00% | – |
| Q2 2015 | $66,000 | -12.0% | 15,743 | -17.3% | 0.00% | – |
| Q1 2015 | $75,000 | -41.9% | 19,044 | -8.8% | 0.00% | – |
| Q4 2014 | $129,000 | +31.6% | 20,886 | 0.0% | 0.00% | – |
| Q3 2014 | $98,000 | -12.5% | 20,886 | -10.3% | 0.00% | – |
| Q2 2014 | $112,000 | – | 23,276 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| BARD ASSOCIATES INC | 124,300 | $87,000 | 0.04% |
| Hayden Royal, LLC | 16,000 | $12,272,000 | 0.01% |
| Global Strategic Investment Solutions, LLC | 23,000 | $16,000 | 0.01% |
| Founders Capital Management | 8,000 | $6,000 | 0.01% |
| Cable Hill Partners, LLC | 20,000 | $14,000 | 0.00% |
| Jacobi Capital Management LLC | 25,000 | $18,000 | 0.00% |
| Stonebridge Capital Advisors LLC | 22,000 | $15,000 | 0.00% |
| B. Riley Wealth Advisors, Inc. | 37,520 | $27,000 | 0.00% |
| Firestone Capital Management | 5,200 | $4,000 | 0.00% |
| MGO ONE SEVEN LLC | 10,615 | $7,000 | 0.00% |